Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood von Glantz, L.A, Gilmore, J.H, Hamer, R.M, Lieberman, J.A, Jarskog, L.F

Volltext

Developmental regulation of neural cell adhesion molecule in human prefrontal cortex von Cox, E.T, Brennaman, L.H, Gable, K.L, Hamer, R.M, Glantz, L.A, LaMantia, A.-S, Lieberman, J.A, Gilmore, J.H, Maness, P.F, Jarskog, L.F

Volltext

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents von Miyamoto, S, Miyake, N, Jarskog, L F, Fleischhacker, W W, Lieberman, J A

Volltext

Cytokine regulation of apoptosis in fetal substantia nigra cultures von Jarskog, L.F., Gilmore, J.H.

Volltext

Decreased PAR-4 in the temporal cortex of subjects with schizophrenia von Glantz, L.A., Gilmore, J.H., Lieberman, J.A., Jarskog, L.F.

Volltext

73. BCL-2 protein reduced in schizophrenic temporal cortex von Jarskog, L.F., Gilmore, J.H., Selinger, E.S., Lieberman, J.A.

Volltext

144. Cytokine regulation of embryonic cortical neuron survival: implications for schizophrenia von Marx, C.E., Jarskog, L.F., Lauder, J.M., Lieberman, J.A., Gilmore, J.H.

Volltext

108. Developmental expression of NGF, NT-3 and BDNF mRNA in human cortex von Gilmore, J.H., Xiao, H., Jarskog, L.F., Watson, N.F.

Volltext

390. Nerve growth factor levels in schizophrenia in response to stress von Jarskog, L.F., Perkins, D.O., Graham, K.A., Broadwell, S., Regan, J.J.

Volltext

Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness von Gilmore, J.H., Jarskog, L.F., Lindgren, J.C., McEvoy, J.P., Xiao, H.

Volltext